1. Manning DS, Afdhal NH [Diagnosis and Quantification of fibrosis] Gastroenterology. 2008; 134 (6): 1670-1681. English
http://dx.doi.org/10.1053/j.gastro.2008.03.001 |
|
2. Regev A, Berho M, Jeffers LJ. [Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection] Am J Gastroenterol. 2002; 97: 2614—2618. English
http://dx.doi.org/10.1111/j.1572-0241.2002.06038.x |
|
3. Lindor KD, Bru C, Jorgensen RA. [The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy] Hepatology. 1996; 23: 1079— 1083. English
http://dx.doi.org/10.1002/hep.510230522 |
|
4. Thampanitchawong P, Piratvisuth T. [Liver biopsy: complications and risk factors] World J Gastroenterol. 1999; 5: 301—304. English
http://dx.doi.org/10.3748/wjg.v5.i4.301 |
|
5. Terjung B, Lemnitzer I, Dumoulin FL. [Bleeding complications after percutaneous liver biopsy (An analysis of risk factors)] Digestion. 2003; 67: 138—145. English
http://dx.doi.org/10.1159/000071293 |
|
6. Poniachik J, Bernstein DE, Reddy KR. [The role of laparoscopy in the diagnosis of cirrhosis]. Gastrointest Endosc. 1996; 43: 568—571. English
http://dx.doi.org/10.1016/S0016-5107(96)70192-X |
|
7. Bedossa P, Dargere D, Paradis V. [Sampling variability of liver fibrosis in chronic hepatitis C]. Hepatology. 2003; 38: 1449—1457. English
http://dx.doi.org/10.1053/jhep.2003.09022 |
|
| 8. OBrien MJ, Keating NM, Elderiny S. [An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C]. Am J Clin Pathol. 2000; 114: 712—718. English |
|
9. Parkes J, Guha IN, Roderick P. [Performance of serum marker panels for liver fibrosis in chronic hepatitis C]. J Hepatol. 2006; 44: 462—474. English
http://dx.doi.org/10.1016/j.jhep.2005.10.019 |
|
10. Imbert-Bismut F, Ratziu V, Pieroni L. [Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study]. Lancet. 2001; 357: 1069—1075. English
http://dx.doi.org/10.1016/S0140-6736(00)04258-6 |
|
11. Thabut D, Simon M, Myers RP. [Noninvasive prediction of fibrosis in patients with chronic hepatitis] Hepatology. 2003; 37: 1220—1221. English
http://dx.doi.org/10.1053/jhep.2003.50109 |
|
12. Wai CT, Greenson JK, Fontana RJ. [A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C]. Hepatology. 2003; 38: 518—526. English
http://dx.doi.org/10.1053/jhep.2003.50346 |
|
13. Anderson FH, Zeng L, Rock NR. [An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C]. Hepatol Res. 2000; 18: 63—71. English
http://dx.doi.org/10.1016/S1386-6346(99)00085-6 |
|
14. Park GJ, Lin BP, Ngu MC. [Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?]. J GastroenterolHepatol. 2000; 15: 386—390. English
http://dx.doi.org/10.1046/j.1440-1746.2000.02172.x |
|
15. Kawasaki T, Takeshita A, Souda K. [Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis]. Am J Gastroenterol. 1999; 94: 1918—1922. English
http://dx.doi.org/10.1111/j.1572-0241.1999.01231.x |
|
16. Shaheen AA, Myers RP. [Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review]. Hepatology. 2007; 46: 912—921. English
http://dx.doi.org/10.1002/hep.21835 |
|
17. Teare JP, Sherman D, Greenfield SM. [Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis]. Lancet. 1993; 342: 895—898. English
http://dx.doi.org/10.1016/0140-6736(93)91946-J |
|
18. Rossi E, Adams L, Prins A. [Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients]. Clin Chem. 2003; 49: 450—454. English
http://dx.doi.org/10.1373/49.3.450 |
|
19. Poynard T, Morra R, Halfon P. [Meta-analyses of Fibrotest diagnostic value in chronic liver disease]. BMC Gastroenterol. 2007; 7: 40 English
http://dx.doi.org/10.1186/1471-230X-7-40 |
|
20. Pares A, Deulofeu R, Gimenez A. [Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis]. Hepatology. 1996; 24: 1399—1403. English
http://dx.doi.org/10.1002/hep.510240615 |
|
21. Giannini E, Caglieris S, Ceppa P. [Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C]. Eur J Gastroenterol Hepatol. — 2001; 13: 137—141. English
http://dx.doi.org/10.1097/00042737-200102000-00008 |
|
22. Khan S, Subedi D, Chowdhury MM. [Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis]. Postgrad Med J. 2006; 82: 353—354. English
http://dx.doi.org/10.1136/pgmj.2005.041533 |
|
23. Boeker KH, Haberkorn CI, Michels D. [Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C]. ClinChimActa. 2002; 316: 71—81. English
http://dx.doi.org/10.1016/S0009-8981(01)00730-6 |
|
24. Larrousse M, Laguno M, Segarra M. [Noninvasive diagnosis of hepatic fibrosis in HIV/HCV-coinfected patients]. J Acquir Immune DeficSyndr. 2007; 46: 304—311. English
http://dx.doi.org/10.1097/QAI.0b013e3181520502 |
|
25. McClain CJ, Cohen DA. [Increased tumor necrosis factor production by monocytes in alcoholic hepatitis]. Hepatology. 1989; 9: 349—351. English
http://dx.doi.org/10.1002/hep.1840090302 |
|
26. Ikura Y, Morimoto H, Ogami M. [Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease]. J Gastroenterol. 1997; 32: 496—501. English
http://dx.doi.org/10.1007/BF02934089 |
|
27. Rosenberg WM, Michael V, Robert T. [Serum markers detect the presence of liver fibrosis: A cohort study]. Gastroenterology. 2012; 127 (6): 1704-1713. English
http://dx.doi.org/10.1053/j.gastro.2004.08.052 |
|
28. Kelleher TB, Mehta SH, Bhaskar R. [Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index]. J Hepatol. 2005; 43: 78—84. English
http://dx.doi.org/10.1016/j.jhep.2005.02.025 |
|
| 29. Honda H, Onitsuka H, Masuda K. [Chronic liver disease: value of volumetry of liver and spleen with computed tomography]. Radiat Med. 1990; 8: 222—226. English |
|
30. Kettaneh A, Marcellin P, Douvin C. [Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients]. J Hepatol. 2007; 46: 628—634. English
http://dx.doi.org/10.1016/j.jhep.2006.11.010 |
|
31. Ziol M, Handra-Luca A, Kettaneh A. [Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C]. Hepatology. 2005; 41: 48—54. English
http://dx.doi.org/10.1002/hep.20506 |
|
32. Talwalkar JA, Kurtz DM, Schoenleber SJ. [Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis]. ClinGastroenterolHepatol. 2007; 5: 1214—1220. English
http://dx.doi.org/10.1016/j.cgh.2007.07.020 |
|
33. Shaheen AA, Wan AF, Myers RP. [FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy]. Am J Gastroenterol. 2007; 102: 2589—2600. English
http://dx.doi.org/10.1111/j.1572-0241.2007.01466.x |
|
34. Huwart L, Peeters F, Sinkus R. [Liver fibrosis: noninvasive assessment with MR elastography]. NMR Biomed. 2006; 19: 173—179. English
http://dx.doi.org/10.1002/nbm.1030 |
|
35. Yin M, Talwalkar JA, Glaser KJ. [Assessment of hepatic fibrosis with magnetic resonance elastography]. ClinGastroenterolHepatol. 2007; 5: 1207—1213. English
http://dx.doi.org/10.1016/j.cgh.2007.06.012 |